by Peter Ciszewski | Aug 20, 2019
Spark Therapeutics is developing a gene therapy to treat one of the most devastating genetic disease known – Huntington’s disease. A disease that robs people of their motor skills and psychological stability in the prime of their life. Recently, we talked with...
by Peter Ciszewski | Aug 19, 2019
Prof. Arndt Rolfs, MD, Chief Executive Officer at Centogene discuses the challenges of diagnostic testing and how Centogene is overcoming some of these challenges. There is no current gold standard for genetic testing and companies such as Centogene are...
by Peter Ciszewski | Aug 16, 2019
Hideki Garren, MD, PhD, global head of neuroimmunology at Roche, discusses neuromyelitis optica spectrum disease (NMOSD), a rare autoimmune disease that affects the central nervous system that often leads to damaged optic nerves and spinal cord. Blindness,...
by Peter Ciszewski | Aug 14, 2019
Heather A. Lau, MD, Assistant Professor, Department of Neurology; Associate Director, Division of Neurogenetics; Director, Lysosomal Storage Disease Program at NYU Langone Health, discusses some of the approved and emerging therapies for mucopolysaccharidoses...
by Peter Ciszewski | Aug 13, 2019
Prof. Arndt Rolfs, MD, Chief Executive Officer at Centogene discuses the challenges of diagnosing rare diseases and how rare diseases need to be considered early in the diagnostic work up. Although physicians may not consider rare diseases in their daily...
